Transenterix Company Profile (NASDAQ:TRXC)

About Transenterix (NASDAQ:TRXC)

Transenterix logoTransEnterix, Inc. is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company's ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera. The system features advanced technology to enable surgeons with haptic feedback and the ability to move the camera through eye movement. The system replicates laparoscopic motion and integrates three-dimensional high definition (3DHD) vision technology. The ALF-X System also offers responsible economics to hospitals by offering robotic technology with reusable instruments. The SurgiBot System is designed as a single-incision, patient-side robotic-assisted surgery system. The Company also develops and manufactures laparoscopic surgical instruments that are used in abdominal surgery, such as scissors, graspers, clip appliers, and suction and irrigation instruments.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Equipment, Supplies & Distribution - NEC
  • Sub-Industry: N/A
  • Symbol: NASDAQ:TRXC
  • CUSIP: N/A
  • Web: www.transenterix.com
Capitalization:
  • Market Cap: $109.17 million
  • Outstanding Shares: 148,529,000
Average Prices:
  • 50 Day Moving Avg: $0.64
  • 200 Day Moving Avg: $1.00
  • 52 Week Range: $0.45 - $2.33
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.93
  • P/E Growth: 0.000
Sales & Book Value:
  • Annual Revenue: $3.46 million
  • Price / Sales: 31.55
  • Book Value: $0.94 per share
  • Price / Book: 0.78
Profitability:
  • EBIDTA: ($47,590,000.00)
  • Net Margins: -792.09%
  • Return on Equity: -52.81%
  • Return on Assets: -36.09%
Misc:
  • Average Volume: 1.36 million shs.
  • Short Ratio: 5.89
 

Frequently Asked Questions for Transenterix (NASDAQ:TRXC)

What is Transenterix's stock symbol?

Transenterix trades on the NASDAQ under the ticker symbol "TRXC."

When will Transenterix make its next earnings announcement?

Transenterix is scheduled to release their next quarterly earnings announcement on Wednesday, August, 2nd 2017. View Earnings Estimates for Transenterix.

Where is Transenterix's stock going? Where will Transenterix's stock price be in 2017?

1 brokers have issued 12 month price targets for Transenterix's stock. Their predictions range from $0.70 to $0.70. On average, they expect Transenterix's stock price to reach $0.70 in the next year. View Analyst Ratings for Transenterix.

Who are some of Transenterix's key competitors?

Who are Transenterix's key executives?

Transenterix's management team includes the folowing people:

  • Paul A. LaViolette, Independent Chairman of the Board
  • Todd M. Pope, President, Chief Executive Officer, Director
  • Joseph P. Slattery CPA, Chief Financial Officer, Executive Vice President, IR Contact Officer
  • Anthony Fernando, Chief Operating Officer
  • Andrea Biffi, Director
  • Dennis J. Dougherty, Independent Director
  • Jane H. Hsiao Ph.D., Independent Director
  • William N. Kelley M.D., Independent Director
  • Aftab R. Kherani M.D., Independent Director

How do I buy Transenterix stock?

Shares of Transenterix can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Transenterix's stock price today?

One share of Transenterix stock can currently be purchased for approximately $0.74.


MarketBeat Community Rating for Transenterix (NASDAQ TRXC)
Community Ranking:  1.8 out of 5 ()
Outperform Votes:  11 (Vote Outperform)
Underperform Votes:  20 (Vote Underperform)
Total Votes:  31
MarketBeat's community ratings are surveys of what our community members think about Transenterix and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Transenterix (NASDAQ:TRXC) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $0.70 (4.76% downside)

Analysts' Ratings History for Transenterix (NASDAQ:TRXC)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/16/2017B. RileyDowngradeNeutral$0.70LowView Rating Details
(Data available from 7/21/2015 forward)

Earnings

Earnings History for Transenterix (NASDAQ:TRXC)
Earnings by Quarter for Transenterix (NASDAQ:TRXC)
Earnings History by Quarter for Transenterix (NASDAQ TRXC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/3/2017($0.11)N/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Transenterix (NASDAQ:TRXC)
Current Year EPS Consensus Estimate: $-0.440 EPS
Next Year EPS Consensus Estimate: $-0.380 EPS

Dividends

Dividend History for Transenterix (NASDAQ:TRXC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Transenterix (NASDAQ:TRXC)
Insider Trades by Quarter for Transenterix (NASDAQ:TRXC)
Insider Trades by Quarter for Transenterix (NASDAQ:TRXC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/16/2017Richard C Pfenniger JrDirectorBuy100,000$0.54$54,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Transenterix (NASDAQ:TRXC)
Latest Headlines for Transenterix (NASDAQ:TRXC)
Source:
DateHeadline
americanbankingnews.com logoAnalysts Expect Transenterix Inc (NASDAQ:TRXC) to Post ($0.11) EPS
www.americanbankingnews.com - July 21 at 8:48 AM
americanbankingnews.com logoTransenterix Inc (NASDAQ:TRXC) Expected to Post Quarterly Sales of $870,000.00
www.americanbankingnews.com - July 9 at 10:20 AM
americanbankingnews.com logoTransenterix Inc (TRXC) Expected to Announce Earnings of -$0.11 Per Share
www.americanbankingnews.com - July 7 at 8:08 AM
prnewswire.com logoStock Performance Review on Medical Supplies Industry -- TransEnterix, Dextera Surgical, Ekso Bionics, and Mazor Robotics
www.prnewswire.com - July 6 at 2:23 PM
americanbankingnews.com logoAnalysts Expect Transenterix Inc (TRXC) to Post ($0.11) EPS
www.americanbankingnews.com - July 6 at 8:44 AM
americanbankingnews.com logoAnalysts Anticipate Transenterix Inc (TRXC) to Announce ($0.11) Earnings Per Share
www.americanbankingnews.com - June 19 at 2:30 PM
streetinsider.com logoTransEnterix (TRXC) Sells Senhance Robotic Surgery System at Saitama Medical University International Medical Center in Japan
www.streetinsider.com - June 15 at 3:34 PM
nasdaq.com logoMid-Day ETF Update: ETFs, Stocks in the Red as Political Woes, Mixed Economic Data Drive Sentiment Lower
www.nasdaq.com - June 15 at 3:34 PM
finance.yahoo.com logoTransEnterix Announces Sale of Senhance™ Robotic Surgery System at Saitama Medical University International Medical Center in Japan
finance.yahoo.com - June 15 at 3:34 PM
americanbankingnews.com logo$110,000.00 in Sales Expected for Transenterix Inc (TRXC) This Quarter
www.americanbankingnews.com - June 15 at 11:58 AM
americanbankingnews.com logoZacks: Analysts Expect Transenterix Inc (TRXC) to Post -$0.11 EPS
www.americanbankingnews.com - June 13 at 8:46 AM
americanbankingnews.com logoAnalysts Anticipate Transenterix Inc (TRXC) to Post ($0.11) EPS
www.americanbankingnews.com - June 1 at 2:48 PM
americanbankingnews.com logo Brokerages Anticipate Transenterix Inc (TRXC) Will Post Quarterly Sales of $110,000.00
www.americanbankingnews.com - May 21 at 10:54 AM
americanbankingnews.com logoRichard C. Pfenniger, Jr. Purchases 100,000 Shares of Transenterix Inc (TRXC) Stock
www.americanbankingnews.com - May 17 at 10:22 AM
americanbankingnews.com logo Analysts Set $2.82 Price Target for Transenterix Inc (TRXC)
www.americanbankingnews.com - May 17 at 12:44 AM
americanbankingnews.com logoTransenterix Inc (TRXC) Downgraded by B. Riley to "Neutral"
www.americanbankingnews.com - May 16 at 6:58 PM
americanbankingnews.com logo Analysts Expect Transenterix Inc (TRXC) to Announce -$0.11 EPS
www.americanbankingnews.com - May 16 at 4:06 PM
zacks.com logoTransEnterix (TRXC) Reports Wider-than-Expected Loss in Q1
www.zacks.com - May 15 at 8:50 AM
americanbankingnews.com logoTransenterix Inc (TRXC) Rating Lowered to Neutral at B. Riley
www.americanbankingnews.com - May 14 at 9:36 AM
americanbankingnews.com logoTransenterix Inc (TRXC) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - May 11 at 11:56 AM
americanbankingnews.com logoTransenterix Inc (TRXC) Upgraded to "Buy" by Zacks Investment Research
www.americanbankingnews.com - May 10 at 8:56 AM
americanbankingnews.com logoTransenterix Inc (TRXC) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - March 22 at 11:55 AM
bizjournals.com logoTransEnterix CEO gives FDA clearance outlook
www.bizjournals.com - March 7 at 8:12 PM
us.rd.yahoo.com logoTransEnterix, Inc. Reports Operating Results for the Fourth Quarter and Full Year 2016
us.rd.yahoo.com - March 6 at 7:37 PM
biz.yahoo.com logoTRANSENTERIX INC. Files SEC form 10-K, Annual Report
biz.yahoo.com - March 6 at 7:37 PM
uk.finance.yahoo.com logoTransEnterix Completes Sale of the Senhance™ Surgical System in Germany
uk.finance.yahoo.com - February 23 at 10:40 PM
biz.yahoo.com logoTRANSENTERIX INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
biz.yahoo.com - February 23 at 10:40 PM
finance.yahoo.com logoTransEnterix to Present at the Cowen and Company 37th Annual Health Care Conference
finance.yahoo.com - February 22 at 10:32 AM
streetinsider.com logoTransEnterix (TRXC) Reports First Clinical Use of Senhance Robotic Surgical System in France - StreetInsider.com
www.streetinsider.com - February 14 at 6:40 AM
uk.finance.yahoo.com logoTransEnterix Announces First Clinical Use of Senhance™ Robotic Surgical System in France
uk.finance.yahoo.com - February 14 at 6:40 AM
finance.yahoo.com logoTransEnterix to Present at the RBC Capital Markets Global Healthcare Conference
finance.yahoo.com - February 10 at 6:14 AM
nasdaq.com logo3 Reasons TransEnterix Inc Stock Could Fall - Nasdaq
www.nasdaq.com - February 5 at 8:07 PM
fool.com logo3 Reasons TransEnterix Inc Stock Could Fall
www.fool.com - February 5 at 8:07 PM
finance.yahoo.com logoTransenterix downgraded by Raymond James
finance.yahoo.com - January 20 at 7:15 AM
us.rd.yahoo.com logoTransEnterix, Inc. Announces $5.2 million Investment by SOFAR S.p.A
us.rd.yahoo.com - January 5 at 7:15 AM
bizjournals.com logoSeeking FDA approval, TransEnterix opens new surgical robotics facility
us.rd.yahoo.com - December 20 at 4:50 PM
us.rd.yahoo.com logoTransEnterix Announces Common Stock Purchase Agreement by Institutional Investor, Lincoln Park Capital Fund, LLC
us.rd.yahoo.com - December 20 at 4:50 PM
us.rd.yahoo.com logo6:51 am Transenterix to sell to Lincoln Park Capital up to $25 mln of its common stock over a 36-month period
us.rd.yahoo.com - December 20 at 4:50 PM

Social

Chart

Transenterix (TRXC) Chart for Friday, July, 21, 2017

This page was last updated on 7/21/2017 by MarketBeat.com Staff